Bioceros, J&J deal

Bioceros said its BiocerOX Products B.V. affiliate granted Johnson & Johnson's Janssen Pharmaceuticals Inc. subsidiary exclusive, worldwide rights to develop a mAb directed at an undisclosed immune ch...